An A1C value today has consequences for outcomes tomorrow. That’s the message John M. Lachin, ScD, will deliver during a Saturday morning symposium that will explore the long-term benefits of short-term tight glycemic management.
One of the most recent developments in diabetes research is the use of organoids, sometimes called “organs in a dish,” which are three-dimensional structures grown in a lab that mimic human organs in vivo. Four researchers, including Linda G. Griffith, PhD, will describe the current state and future potential of organoid and ‘physiomimetic’ research during…
A better understanding of the islets of Langerhans could lead to a new area of diabetes treatment, according to Barak Blum, PhD, one of three researchers who will provide an update on islet research during a Saturday afternoon symposium at the Virtual 80th Scientific Sessions.
Soon, many more individuals with monogenic diabetes will be properly recognized, diagnosed, and treated thanks to genetic research being conducted to improve personalized medicine for diabetes patients, according to Toni I. Pollin, MS, PhD, CGC. That research, along with other important genetic studies, will be discussed during a Saturday afternoon symposium.
Join Boris Draznin, MD, PhD, a leading endocrinologist and developer of the A1CVD Pro app, during a targeted virtual case review session on Sunday or Monday at the Scientific Sessions.
ADA Imagine Camp, which launched June 8, is an innovative program helping youth with diabetes make new friends, build confidence and independence in diabetes management, and join in traditions from camps, partners, and programs across the country.
Lydia Finley, PhD, one of the speakers planned for the symposium Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14, talks about her background and previews her presentation, “Metabolic Regulation of Cell Fate Decisions,” which begins at 9:20 a.m. CT Sunday, June 14.
Cecilia C. Low Wang, MD, FACP, previews her presentation “Management of Steroid-Associated Hyperglycemia in Inpatient and Outpatient Settings,” which begins at 11:40 a.m. CT Saturday, June 13.
Korey Hood, PhD, previews his presentation “Is One Size Fits All Actually A Bad Approach?” which beings at 4:30 p.m. CT Saturday, June 13.
Bruce Verchere, PhD, previews his presentation “Pro-Islet Amyloid Polypeptide Processing in Diabetes,” which begins at 2:45 p.m. CT Saturday, June 13.